Fecal Calprotectin Test Market
完整報告名稱與涵蓋範圍
Fecal Calprotectin Test Market Size, Share & Trends Analysis Report By Patient Type (Adult and Pediatric), By Assay Type (ELISA [Enzyme Linked Immunosorbent Assay], Enzyme Fluoroimmunoassay, and Quantitative Immune-chromatography)), By Indication, By End-user, By Region, Forecasts, 2024-2031
報告摘要
The Fecal Calprotectin Test Market on a global scale was estimated at USD 140.2 Mn in 2023 and is forecasted to attain USD 280.5 Mn by 2031, with a projected CAGR of 9.17% between 2024 and 2031.
Fecal Calprotectin Test encompasses challenges.
Growth is driven by a convergence of factors: rising awareness among end users, continuous product innovation, and the escalating emphasis on efficiency and sustainability within the healthcare sector.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, driven by rapid industrialization and expanding end-user bases.
Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Fecal Calprotectin Test Market Snapshot
Chapter 4. Global Fecal Calprotectin Test Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Patient Type Estimates & Trend Analysis
5.1. By Patient Type & Market Share, 2023 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Patient Type:
5.2.1. Adult
5.2.2. Pediatric
Chapter 6. Market Segmentation 2: By Assay Type Estimates & Trend Analysis
6.1. By Assay Type & Market Share, 2023 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Assay Type:
6.2.1. ELISA (Enzyme linked Immunosorbent Assay)
6.2.2. Enzyme Fluoroimmunoassay
6.2.3. Quantitative Immune-chromatography
Chapter 7. Market Segmentation 3: By Indication Estimates & Trend Analysis
7.1. By Indication & Market Share, 2023 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Indication:
7.2.1. Inflammatory Bowel Disease
7.2.2. Colorectal Cancer
7.2.3. Celiac Disease
Chapter 8. Market Segmentation 4: by End User Estimates & Trend Analysis
8.1. by End User & Market Share, 2023 & 2031
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End User:
8.2.1. Hospitals
8.2.2. Diagnostic Laboratories
8.2.3. Academic & Research Institutes
Chapter 9. Fecal Calprotectin Test Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by Patient Type, 2024-2031
9.1.2. North America Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
9.1.3. North America Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by Assay Type, 2024-2031
9.1.4. North America Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2024-2031
9.1.5. North America Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
9.2. Europe
9.2.1. Europe Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by Patient Type, 2024-2031
9.2.2. Europe Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
9.2.3. Europe Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by Assay Type, 2024-2031
9.2.4. Europe Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2024-2031
9.2.5. Europe Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
9.3. Asia Pacific
9.3.1. Asia Pacific Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by Patient Type, 2024-2031
9.3.2. Asia Pacific Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
9.3.3. Asia Pacific Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by Assay Type, 2024-2031
9.3.4. Asia Pacific Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2024-2031
9.3.5. Asia Pacific Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
9.4. Latin America
9.4.1. Asia Pacific Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by Patient Type, 2024-2031
9.4.2. Asia Pacific Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
9.4.3. Latin America Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by Assay Type, 2024-2031
9.4.4. Latin America Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2024-2031
9.4.5. Latin America Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
9.5. Middle East & Africa
9.5.1. Middle East & Africa Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by Patient Type, 2024-2031
9.5.2. Middle East & Africa Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
9.5.3. Middle East & Africa Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by Assay Type, 2024-2031
9.5.4. Middle East & Africa Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2024-2031
9.5.5. Middle East & Africa Fecal Calprotectin Test Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Abbexa
10.2.2. ALPCO
10.2.3. Alpha Laboratories
10.2.4. Biomerica
10.2.5. BÜHLMANN Laboratories AG
10.2.6. DRG Instruments GmbH
10.2.7. EagleBio
10.2.8. Epitope Diagnostics, Inc.
10.2.9. OPERON, S.A.
10.2.10. R-Biopharm AG
10.2.11. Svar Life Science
10.2.12. Thermo Fisher Scientific Inc.
10.2.13. Werfen
10.2.14. SENTINEL CH. SpA
10.2.15. Diazyme Laboratories, Inc.
10.2.16. DiAgam
10.2.17. Other Prominent Players
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們